BRPI0716108B8 - composição, uso de uma composição, e, método para fabricação de uma composição - Google Patents

composição, uso de uma composição, e, método para fabricação de uma composição

Info

Publication number
BRPI0716108B8
BRPI0716108B8 BRPI0716108A BRPI0716108A BRPI0716108B8 BR PI0716108 B8 BRPI0716108 B8 BR PI0716108B8 BR PI0716108 A BRPI0716108 A BR PI0716108A BR PI0716108 A BRPI0716108 A BR PI0716108A BR PI0716108 B8 BRPI0716108 B8 BR PI0716108B8
Authority
BR
Brazil
Prior art keywords
composition
vitamin
compositions
making
baby
Prior art date
Application number
BRPI0716108A
Other languages
English (en)
Inventor
Vieth Elaine
W Vieth Reinhold
Original Assignee
Vieth Elaine
W Vieth Reinhold
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38283462&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0716108(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
US case filed in Delaware District Court litigation https://portal.unifiedpatents.com/litigation/Delaware%20District%20Court/case/1%3A22-cv-00332 Source: District Court Jurisdiction: Delaware District Court "Unified Patents Litigation Data" by Unified Patents is licensed under a Creative Commons Attribution 4.0 International License.
US case filed in Minnesota District Court litigation https://portal.unifiedpatents.com/litigation/Minnesota%20District%20Court/case/0%3A15-cv-03981 Source: District Court Jurisdiction: Minnesota District Court "Unified Patents Litigation Data" by Unified Patents is licensed under a Creative Commons Attribution 4.0 International License.
US case filed in Minnesota District Court litigation https://portal.unifiedpatents.com/litigation/Minnesota%20District%20Court/case/0%3A16-cv-04278 Source: District Court Jurisdiction: Minnesota District Court "Unified Patents Litigation Data" by Unified Patents is licensed under a Creative Commons Attribution 4.0 International License.
PTAB case IPR2023-00726 filed (Final Written Decision) litigation https://portal.unifiedpatents.com/ptab/case/IPR2023-00726 Petitioner: "Unified Patents PTAB Data" by Unified Patents is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vieth Elaine, W Vieth Reinhold filed Critical Vieth Elaine
Publication of BRPI0716108A2 publication Critical patent/BRPI0716108A2/pt
Publication of BRPI0716108B1 publication Critical patent/BRPI0716108B1/pt
Publication of BRPI0716108B8 publication Critical patent/BRPI0716108B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

composição, uso de uma composição, e, métodos de uso e para fabricação de uma composição composições de vitamina d em triglicerídeos de cadeia média e uso das mesmas na distribuição de uma quantidade nutricional ou terapêutica de vitamina d para um ser humano, particularmente, um bebê. as composições são aplicadas em um objeto, tal como a pele ou no caso de um bebê no mamilo de uma mulher ou bico artificial a partir do qual o bebê suga a composição. o método provê um meio mais apropriado, seguro e eficiente de prover o ser humano com vitamina d. as composições compreendem ainda um ácido graxo livre e/ou monoglicerídeo, um conservante oxidante e, opcionalmente, outras vitaminas.
BRPI0716108A 2006-09-14 2007-05-14 composição, uso de uma composição, e, método para fabricação de uma composição BRPI0716108B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CA002558202A CA2558202A1 (en) 2006-09-14 2006-09-14 Vitamin d compositions and method of administration to infants
CA2,558,202 2006-09-14
CA002578881A CA2578881C (en) 2006-09-14 2007-02-16 Vitamin d compositions and method of administration to a human being
CA2,578,881 2007-02-16
PCT/CA2007/000844 WO2008031188A1 (en) 2006-09-14 2007-05-14 Vitamin d compositions and method of administration to a human being

Publications (3)

Publication Number Publication Date
BRPI0716108A2 BRPI0716108A2 (pt) 2013-01-15
BRPI0716108B1 BRPI0716108B1 (pt) 2019-09-03
BRPI0716108B8 true BRPI0716108B8 (pt) 2021-05-25

Family

ID=38283462

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0716108A BRPI0716108B8 (pt) 2006-09-14 2007-05-14 composição, uso de uma composição, e, método para fabricação de uma composição

Country Status (15)

Country Link
US (2) US9066958B2 (pt)
EP (1) EP2068885B1 (pt)
JP (1) JP5624765B2 (pt)
KR (2) KR20140097412A (pt)
CN (1) CN101969958B (pt)
AU (1) AU2007295888B2 (pt)
BR (1) BRPI0716108B8 (pt)
CA (2) CA2558202A1 (pt)
DK (1) DK2068885T3 (pt)
ES (1) ES2524776T3 (pt)
MX (1) MX2009001156A (pt)
NZ (2) NZ574644A (pt)
PL (1) PL2068885T3 (pt)
PT (1) PT2068885E (pt)
WO (1) WO2008031188A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2558202A1 (en) 2006-09-14 2006-11-23 Reinhold W. Vieth Vitamin d compositions and method of administration to infants
EP2289555A1 (en) * 2009-08-24 2011-03-02 OrgaNext Research B.V. Method of treating frailty
GB2475934A (en) * 2009-12-02 2011-06-08 Fit Bioceuticals Pty Ltd Liquid composition comprising vitamin D
CA2745267C (en) * 2011-07-05 2019-09-24 Reinhold Vieth Iron supplement composition
US9008389B2 (en) * 2012-09-28 2015-04-14 Robert D. Williams System and method for determining the amount of vitamin D generated by a user
JP6552414B2 (ja) * 2013-02-01 2019-07-31 ディードロップス カンパニー 液体メントール組成物
SMT202200464T1 (it) * 2014-05-06 2023-01-13 S I I T S R L Servizio Int Imballaggi Termosaldanti Formulazione oleosa erogabile tramite spray a base di vitamine liposolubili del gruppo d e relativo uso
CN105105149B (zh) * 2015-10-08 2018-05-25 辽宁美天佳生物科技有限公司 一种强化补充维生素d的固体冲剂
EP3397242B1 (en) 2015-12-29 2021-02-03 Noivita S.R.L.S. Lipophilic formulations
WO2018169497A1 (en) * 2017-03-17 2018-09-20 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Spray formulation comprising cholecalciferol (vitamin d3) with improved stability
CN114009786B (zh) * 2021-11-22 2023-04-07 江南大学 一种用于维生素d递送的营养油脂组合物、制备方法及应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149037A (en) * 1962-09-07 1964-09-15 Hoffmann La Roche Vitamin compositions
JPS5452717A (en) 1977-09-29 1979-04-25 Chugai Pharmaceut Co Ltd Stable oily pharmaceuticals containing 1alpha-hydroxyvitamin d
CA1331559C (en) * 1986-04-21 1994-08-23 Jon Joseph Kabara Antimicrobial preservative compositions and methods
US5422127A (en) 1992-12-21 1995-06-06 Bristol-Myers Squibb Company Nutritional compositions containing vitamin D esters
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
CA2122431C (en) 1994-04-28 2006-10-10 Reinhold W. Vieth Topical administration of vitamin d to mammals and compositions therefor
US5589468A (en) * 1995-01-13 1996-12-31 Clintec Nutrition Co. Method for providing nutrition to elderly patients
US5620462A (en) 1995-05-01 1997-04-15 Valenti; Diane L. Liquid vitamin and medicine dispenser for infants and toddlers
US5601605A (en) * 1995-08-29 1997-02-11 Crowe; Dewey E. Infant pacifier - fluid administering unit
EP0914126B1 (en) * 1996-06-27 2003-08-27 Janssen Pharmaceutica N.V. Sustained release sufentanil compositions
US6013665A (en) * 1997-12-16 2000-01-11 Abbott Laboratories Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
AUPP332898A0 (en) * 1998-05-04 1998-05-28 Unisearch Limited Pharmaceutical composition
JP4010062B2 (ja) * 1998-09-02 2007-11-21 医療法人社団青藍会 アトピー性皮膚炎を防ぐ保健食品
GB9906009D0 (en) 1999-03-16 1999-05-12 Nycomed Pharma As Product
IL133968A0 (en) 2000-01-10 2001-04-30 Thixo Ltd Therapeutic oils and edible pastes containing the same
US7090862B2 (en) 2001-03-30 2006-08-15 Abbott Laboratories Method of improving the antioxidant status of an infant
US7081248B2 (en) 2001-08-03 2006-07-25 Adisseo France S.A.S. Concentrated water-dispersible vitamin compositions
CN100391464C (zh) 2001-12-03 2008-06-04 诺瓦西股份有限公司 含活性维生素d化合物的药物组合物
US6793959B2 (en) * 2002-03-18 2004-09-21 Bunge Foods Corporation Low viscosity structured lipid pan release compositions and methods
JP2004065707A (ja) * 2002-08-08 2004-03-04 Taro Kawasaki 乳幼児用おしゃぶりおよびキシリトール入り乳幼児用おしゃぶり
CA2528359A1 (en) * 2003-06-11 2004-12-23 Novacea, Inc. Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
CA2558202A1 (en) 2006-09-14 2006-11-23 Reinhold W. Vieth Vitamin d compositions and method of administration to infants

Also Published As

Publication number Publication date
CN101969958B (zh) 2015-04-08
KR101437706B1 (ko) 2014-09-03
JP2010520850A (ja) 2010-06-17
WO2008031188A1 (en) 2008-03-20
US20080069925A1 (en) 2008-03-20
JP5624765B2 (ja) 2014-11-12
CN101969958A (zh) 2011-02-09
KR20090050061A (ko) 2009-05-19
PL2068885T3 (pl) 2015-04-30
HK1154200A1 (en) 2012-04-13
US9066958B2 (en) 2015-06-30
BRPI0716108A2 (pt) 2013-01-15
PT2068885E (pt) 2014-12-09
AU2007295888A1 (en) 2008-03-20
DK2068885T3 (da) 2014-12-08
NZ599292A (en) 2013-12-20
KR20140097412A (ko) 2014-08-06
AU2007295888B2 (en) 2012-07-12
BRPI0716108B1 (pt) 2019-09-03
EP2068885A1 (en) 2009-06-17
ES2524776T3 (es) 2014-12-12
US20150246062A1 (en) 2015-09-03
CA2578881C (en) 2008-11-04
MX2009001156A (es) 2009-05-13
NZ574644A (en) 2012-04-27
CA2558202A1 (en) 2006-11-23
EP2068885A4 (en) 2012-02-29
EP2068885B1 (en) 2014-11-12
CA2578881A1 (en) 2007-07-18

Similar Documents

Publication Publication Date Title
MX2009001156A (es) Composiciones de vitamina d y metodo de administracion a un ser humano.
Trukhachev et al. Development of technology for food for people with hypersthenic body type
GB2459809A (en) Fatty acid formulations and methods of use thereof
PH12012502279A1 (en) Tube feed formulations and methods for using same
MY150595A (en) Nutritional composition to promote healthy development and growth
DE602005021372D1 (de) Zusammensetzung in mikropellets mit kontrollierter freisetzung von physiologischen wirksubstanzen, verfahren zu ihrer herstellung und ihre verwendung im zootechnischen sektor
WO2009131939A3 (en) Lipid-containing compositions and methods of use thereof
TR201908522T4 (tr) Kan lipidi düşürücü maddeler olarak keton gövdeleri ve keton gövde esterleri.
WO2009101503A3 (fr) Utilisation de substances actives naturelles dans des compositions cosmétiques ou thérapeutiques
BR112012033422A2 (pt) composições nutricionais de proteína alta, hipocalórica e métodos de usar as mesmas
WO2010041017A3 (en) Chewable gelled emulsions
NZ541593A (en) Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
BR0308799A (pt) co-glóbulos de dha e alecrim e método de uso
EP2253305A3 (de) Hautbehandlung zur Porenverfeinerung
WO2004103307A3 (en) Method of use of five and fifteen carbon fatty acids
AR023391A1 (es) Composicion que contiene carnitina e inositol fosfato, util como suplemento dietario o droga
BR112017027909A2 (pt) composição, e, uso de uma composição
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
RU2009134848A (ru) Транквилизатор и функциональный продукт питания
MX346623B (es) Composicones a base de arcilla y polen de abeja, su proceso de preparacion y su uso nutricional y terapeutico.
DE502004009901D1 (de) Solubilisate von ätherischen ölen und anderen stoffen
CN106491511A (zh) 一种肌能修复水光精华液
BRPI0511258A (pt) composições de fator de transferência encapsulado e métodos de uso
DE602006011127D1 (de) Fettsäure-benzenediol-derivate sowie herstellungs- und verwendungsverfahren dafür
TWI633896B (zh) Artificial sebum film and manufacturing method thereof

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/09/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/09/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/05/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B15V Prolongation of time limit allowed